Chinook Therapeutics, Inc.

KDNY | NASDAQ | 0 Sledující

$40.39

0.22%

$0.09

Sledovat

Overview Metrics Financials

Breakdown	12/31/2022 USD	12/31/2021 USD
Total revenue	6,128 -88.13%	51,625 -
Cost of revenue	1,722 +2.07%	1,687 -
Gross profit	4,406 -91.18%	49,938 -
Operating expense	179,224 +37.26%	130,573 -
Operating income	-185,083 -86.88%	-99,038 -
Pretax Income	-180,274 -81.71%	-99,208 -
Tax Provision	4,341 +107.41%	2,093 -
Net income	-184,615 -82.24%	-101,301 -
EPS	-2.87 -29.28%	-2.22 -
Diluted EPS	-2.87 -29.28%	-2.22 -
Average Shares	64,370 +41.14%	45,607 -
Diluted Average Shares	64,370 +41.14%	45,607 -
EBIT	-173,096 -	0 -
EBITDA	-164,196 -187.20%	-57,171 -

Soubory cookie používáme ke zlepšení prohlížení na webu.